Please wait while we open this resource.
K
Clinical reviews
CARDIOPROTECTION IN PATIENTS AT HIGH RISK OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY
American College of Cardiology Foundation
PDF20236 pages217 KB
The document provides an overview of the risks associated with anthracycline chemotherapy, particularly in patients with pre-existing cardiovascular conditions. It emphasizes the importance of risk assessment tools and guidelines from the European Society of Cardiology for managing patients undergoing treatment with anthracyclines. The recommendations include strategies for cardioprotection to minimize the risk of cardiotoxicity, which remains a significant concern in oncology.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology